Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Claire, Leloup"'
Autor:
Nicolas Rosine, Hannah Rowe, Surya Koturan, Hanane Yahia‐Cherbal, Claire Leloup, Abdulla Watad, Francis Berenbaum, Jeremie Sellam, Maxime Dougados, Vishukumar Aimanianda, Richard Cuthbert, Charlie Bridgewood, Darren Newton, Elisabetta Bianchi, Lars Rogge, Dennis McGonagle, Corinne Miceli‐Richard
Publikováno v:
Arthritis & Rheumatology. 74:1786-1795
Autor:
Nicolas, Rosine, Hannah, Rowe, Surya, Koturan, Hanane, Yahia-Cherbal, Claire, Leloup, Abdulla, Watad, Francis, Berenbaum, Jeremie, Sellam, Maxime, Dougados, Vishukumar, Aimanianda, Richard, Cuthbert, Charlie, Bridgewood, Darren, Newton, Elisabetta, Bianchi, Lars, Rogge, Dennis, McGonagle, Corinne, Miceli-Richard
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.)REFERENCES. 74(11)
The importance of interleukin-17A (IL-17A) in the pathogenesis of axial spondyloarthritis (SpA) has been demonstrated by the success of IL-17A blockade. However, the nature of the cell populations that produce this important proinflammatory cytokine
Autor:
Vincent Rouilly, Cherie Green, Lluis Quintana-Murci, Julie Hunkapiller, Isabelle Peguillet, Magnus Fontes, Jacob Bergstedt, Alejandra Urrutia, Claire Leloup, Benoit Beitz, Friederike Jönsson, Darragh Duffy, Stéphanie Thomas, François Huetz, Lars Rogge, Cécile Alanio, Matthew L. Albert, Petar Scepanovic, Olivier Lantz, Barbara Piasecka, Yoong Wearn Lim, Jacques Fellay, Hélène Quach, Christian Hammer, Milena Hasan, Etienne Patin, Magge Zepeda, Valentina Libri, James P. Di Santo
Publikováno v:
Nature immunology. 19(6)
In the version of this article initially published, the name of one author was incorrect (James P. Santo). The correct name is James P. Di Santo. The error has been corrected in the HTML and PDF versions of the article.
Autor:
Petar Scepanovic, Julie Hunkapiller, Jacob Bergstedt, Alejandra Urrutia, Jacques Fellay, Lluis Quintana-Murci, Hélène Quach, Friederike Jönsson, Cherie Green, Olivier Lantz, Lars Rogge, Stéphanie Thomas, Vincent Rouilly, Barbara Piasecka, Yoong Wearn Lim, Claire Leloup, Cécile Alanio, Isabelle Peguillet, Christian Hammer, Benoit Beitz, Magnus Fontes, Magge Zepeda, Matthew L. Albert, Valentina Libri, James P. Di Santo, Etienne Patin, Milena Hasan, François Huetz, Darragh Duffy
Publikováno v:
Nature Immunology
Nature Immunology, 2018, 19 (3), pp.302-314. ⟨10.1038/s41590-018-0049-7⟩
Nature Immunology, Nature Publishing Group, 2018, 19 (3), pp.302-314. ⟨10.1038/s41590-018-0049-7⟩
Nature Immunology, 2018, 19 (3), pp.302-314. ⟨10.1038/s41590-018-0049-7⟩
Nature Immunology, Nature Publishing Group, 2018, 19 (3), pp.302-314. ⟨10.1038/s41590-018-0049-7⟩
A Publisher Correction to this article was published on 03 May 2018; International audience; The quantification and characterization of circulating immune cells provide key indicators of human health and disease. To identify the relative effects of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7632e50a0858023a8e68c6aaad539182
https://hal-pasteur.archives-ouvertes.fr/pasteur-01768943
https://hal-pasteur.archives-ouvertes.fr/pasteur-01768943
Publikováno v:
European Journal of Immunology. 44:2880-2892
Robust cell-mediated immunity is required for immune control of tumours and protection from viral infections, with both CD4+ and CD8+ T cells playing a pivotal role. Synthetic long peptides (SLPs) represent an attractive way to induce such combined r
Publikováno v:
European journal of immunology. 44(10)
Robust cell-mediated immunity is required for immune control of tumours and protection from viral infections, with both CD4(+) and CD8(+) T cells playing a pivotal role. Synthetic long peptides (SLPs) represent an attractive way to induce such combin
Autor:
Jean-Paul Molens, Marie-Thérèse Leccia, Claire Leloup, L. Tramcourt, Julie Charles, Joel Plumas, Caroline Aspord
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 142:S454
Introduction L’imiquimod (IMQ), ligand synthetique des recepteurs Toll-like (TLR)-7/8, possede de puissants effets anti-viraux et anti-tumoraux de par ses proprietes immunomodulatrices et pro-apoptotiques. L’Aldara*, une formulation contenant 5 %
Autor:
Caroline Aspord, Julie Charles, Joel Plumas, Marie-Thérèse Leccia, Jean-Paul Molens, Laetitia Tramcourt, Claire Leloup
Publikováno v:
Journal of Investigative Dermatology. (10):2551-2561
Imiquimod (IMQ) is a synthetic Toll-like receptor (TLR7/8) ligand that can trigger antiviral and antitumor activities. Despite evidence of potent therapeutic effects, the clinical use of IMQ in melanoma is impeded by incomplete understanding of its m